FMC Corporation, a leading global agricultural sciences company, today announced the election of Dr. Patricia Verduin to the company's Board of Directors, effective July 17, 2023. She will serve on the Compensation and Organization Committee and the Sustainability Committee.
Verduin has spent her career advancing research and innovation that improves the health and wellbeing of people, their pets and the planet. She has extensive experience in regulatory, supply chain, quality and compliance, making her an astute navigator of global regulatory environments which will provide valuable perspectives to the Board and to FMC. She most recently served as Chief Technology & Science Officer of Colgate Palmolive Company from 2009 to 2023, where she led a global team of over 2,000 scientists, engineers, designers, regulatory and compliance specialists. Prior to her role at Colgate Palmolive, she held leadership positions at Conagra, Nabisco and the Consumer Brands Association. Verduin currently sits on the boards of Ingredion Corporation and Avient Corporation, as well as The Valley Hospital of Ridgewood, NJ. She previously was a director of Monsanto Company, through the closing of its acquisition by Bayer. She holds a PhD in Food Chemistry from Rutgers University and an MBA from Fairleigh Dickinson University.
“We are honored to welcome Pat to the FMC Board of Directors,” said Mark Douglas, FMC president and chief executive officer. “She brings extensive experience driving innovation and a broad skillset in research and development, pipeline growth and plant science. The Board looks forward to her engagement and insight.”
Verduin commented, “I am honored to join the FMC Board. The company has shown itself to be a leading driver of innovation in crop protection. I look forward to working with the CEO, Mark Douglas, the directors and management team in supporting growth and building long-term shareholder value.”
